State Of Wyoming Fulgent Genetics, Inc. Transaction History

State Of Wyoming

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$26.74 - $40.81 $85,354 - $130,265	3,192 Added 171.71%	5,051 $135,000
Q2 2023 Aug 14, 2023	SELL	$28.52 - $40.7 $52,819 - $75,376	-1,852 Reduced 49.91%	1,859 $68,000
Q1 2023 May 12, 2023	SELL	$29.39 - $36.27 $48,581 - $59,954	-1,653 Reduced 30.82%	3,711 $115,000
Q4 2022 Feb 14, 2023	BUY	$29.23 - $40.28 $74,361 - $102,472	2,544 Added 90.21%	5,364 $159,000
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $67,383 - $113,265	1,777 Added 170.37%	2,820 $107,000
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $49,419 - $64,632	1,030 Added 7923.08%	1,043 $57,000
Q1 2022 May 13, 2022	SELL	$49.85 - $96.11 $10,368 - $19,990	-208 Reduced 94.12%	13 $1,000
Q4 2021 Feb 11, 2022	BUY	$77.3 - $105.0 $15,305 - $20,790	198 Added 860.87%	221 $22,000
Q3 2021 Feb 11, 2022	SELL	$74.87 - $110.87 $26,878 - $39,802	-359 Reduced 93.98%	23 $2,000
Q2 2021 Feb 11, 2022	BUY	$66.8 - $100.45 $24,181 - $36,362	362 Added 1810.0%	382 $35,000
Q1 2021 Feb 08, 2022	BUY	$59.3 - $183.85 $1,186 - $3,677	20 New	20 $2,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.